Bio-Rad Quality Controls Now Available for Multiple Abbott Clinical Diagnostics Platforms
Date: 12/03/2018 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced expanded global access of the company’s quality controls across multiple Abbott clinical diagnostics platforms that now includes the Abbott Alinity ci-series instruments. “We are pleased to fulfill this need and offer customers... Read more